Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 8:00 PM JST
Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.20220008340PROCESS FOR EXTRACTING SUBSTANCES OF INTEREST
US 13.01.2022
Int.Class A61K 9/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
19lyophilised
Appl.No 17297530 Applicant AVIGNON UNIVERSITE Inventor Christiane Contino-Pepin

The present description relates to a method for extracting at least one substance of interest, the method comprising the following steps: —providing an admixture comprising water, a source comprising the at least one substance of interest or at least one precursor thereof, at least one surfactant and at least one lipophilic compound; —the emulsification of the admixture, leading to the formation of an emulsion; wherein the emulsion comprises: —a continuous aqueous phase; and a discontinuous lipidic phase comprising the at least one lipophilic compound, the at least one surfactant and at least one substance of interest extracted from the source during the emulsification; wherein the method further comprises the addition of at least one cryoprotectant to the admixture and the lyophilisation of the emulsion.

2.WO/2022/008707TETRASELMIS CHUII (T. CHUII) FOR THE TREATMENT OF MALE INFERTILITY
WO 13.01.2022
Int.Class A61K 36/05
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
02Algae
05Chlorophycota or chlorophyta (green algae), e.g. Chlorella
Appl.No PCT/EP2021/069117 Applicant FITOPLANCTON MARINO, S.L Inventor UNAMUNZAGA ESCOSURA, Carlos
The present invention refers to a biomass of T. chuii and a pharmaceutical composition comprising a biomass of T. chuii for use in the treatment of infertility in a male subject. It also refers to a method for increasing the quality of the semen of a male subject having normozoospermia, not having hypospermia and not having a disorder characterized by a high percentage of sperm DNA fragmentation (SDF), that comprises the administration of a biomass of T. chuii.
3.WO/2022/009442TREATMENT DRUG COMPOSITION FOR NOVEL CORONAVIRUS INFECTIOUS DISEASE, AND METHOD FOR USING SAME
WO 13.01.2022
Int.Class A61K 36/8994
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
8994Coix (Job's tears)
Appl.No PCT/JP2020/040998 Applicant ISHIZUKA, Mitsunori Inventor ISHIZUKA, Mitsunori
At present, there are essentially no fully completed treatment drugs or vaccines against novel coronavirus infectious disease. Precious life is being lost every day, and social and economic losses are immeasurable. We have considered and investigated whether it is impossible to achieve any form of assistance and cooperation under these dangerous conditions; with our conviction obtained though practice and experimentation on foods, we have arrived at the present patent application. We dearly wish that this invention and discovery will be of use to the people of the world, and we strongly desire that the populace will return to peaceful and happy activities by consuming a suitable amount of adlay (yokuinin) once daily. We also strongly desire that this invention and discovery will be developed as a composition for preventive drugs (vaccines) or treatment drugs. In regard to the above, also refer to fig. 5.
4.WO/2022/010387USE OF A PREPARATION OF THE PLANT POLYSCIAS FILICIFOLIA FOR TREATING MINERAL DEFICIENCIES
WO 13.01.2022
Int.Class A61K 36/25
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
Appl.No PCT/RU2021/050238 Applicant KOTIN, Oleg Arkadyevich Inventor KOTIN, Oleg Arkadyevich
Claimed is the use of a preparation(s) of the plant Polyscias filicifolia or fragments thereof for treating mineral deficiencies and the effects thereof in subjects requiring such treatment, where mineral deficiencies are a lack of at least one essential element selected from the group: Ca, Cr, I, Mn in one or more internal organs of the subject resulting from external or internal factors, without the need to use sources or chelators of the essential elements that are lacking.
5.20220008357EYE HEALTH SUPPLEMENT WITH CURCUMIN
US 13.01.2022
Int.Class A61K 31/065
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
065Diphenyl-substituted acyclic alcohols
Appl.No 17448513 Applicant QH Holdings (Oregon), Inc. Inventor James Stringham

An eye health supplement and methods of using the eye health supplement are disclosed.

6.WO/2022/007081TRADITIONAL CHINESE MEDICINE COMPOUND FORMULATION FOR TREATMENT OF PARKINSON’S DISEASE, PREPARATION METHOD THEREFOR AND USE THEREOF
WO 13.01.2022
Int.Class A61K 36/8988
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
898Orchidaceae (Orchid family)
8988Gastrodia
Appl.No PCT/CN2020/106957 Applicant YAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD. Inventor GU, Xiaosong
A traditional Chinese medicine compound formulation for treatment of Parkinson's disease, a preparation method therefor, and a use thereof. The traditional Chinese medicine formulation comprises traditional Chinese medicine formula components. The traditional Chinese medicine formula components comprise the following raw materials or raw material extracts in parts by mass: 6-15 parts Uncaria rhynchophylla, 3-9 parts Gastrodia elata, 6-12 parts Gentiana macrophylla, 10-20 parts Astragalus mongholicus Bunge, 10-20 parts Radix Rehmanniae preparata, 10-20 parts Radix Achyranthis Bidentatae, 10-20 parts Fructus lycii, 10-20 parts Radix Angelicae Sinensis, 10-20 parts stir-baked Rhizoma Atractylodis Macrocephalae, 6-15 parts stir-baked Semen Ziziphi Spinosae, 3-12 parts Semen persicae, 3-9 parts safflower, and 20-30 parts Zaocys dhumnades. The compound formulation is a multi-layered, multi-targeted treatment based on syndrome differentiation taking into consideration of the onset and development of Parkinson's disease, overall patient function, and the principle of “deficiency in origin and excess in superficiality.” The present invention not only has a theoretical basis in modern science, but also has good clinical results, and clearly improves patient quality of life.
7.20220008839SEMI-AQUEOUS METHOD FOR EXTRACTING A SUBSTANCE
US 13.01.2022
Int.Class B01D 11/02
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
DSEPARATION
11Solvent extraction
02of solids
Appl.No 17372399 Applicant David P. Jackson Inventor David P. Jackson

A semi-aqueous method for extracting a substance. The method involves combining a first liquid or solid substance containing an extract with a semi-aqueous solution containing a water-soluble or water-emulsifiable (WSWE) compound. Said WSWE compound selectively dissolves extract during a dense phase CO2 expansion and salting-out process, which is simultaneously co-extracted using said dense phase CO2, and desolvated to produce a CO2 salted-out solvent mixture containing extract. Said CO2 salted-out solvent mixture is treated using various secondary processes. The present invention is useful for producing extracts for use as additives in pharmaceuticals, nutraceuticals, cosmetics, beverages, or foods, and for quantitative analysis.

8.WO/2022/007894METHOD FOR REGULATING EXPRESSION LEVEL OF MUSASHI1 IN CELLS
WO 13.01.2022
Int.Class A61K 31/56
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Appl.No PCT/CN2021/105234 Applicant BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE CO., LTD. Inventor LI, Li
A method for regulating an expression level of Musashi1 in cells. In particular, the present application relates to a cell regulating composition capable of regulating the expression or activity, in cells, of any one selected from the followings: K19, α2β1 integrin, and Musashi1. The regulating composition can promote proliferation, growth, and migration of epidermal cells, promote proliferation, growth, and migration of vascular endothelial cells, and promote proliferation, growth, and migration of fibroblasts.
9.WO/2022/010024HERBAL COMPOSITION FOR ALLEVIATING OR TREATING ATOPIC DERMATITIS, COMPRISING NATURAL COMPOSITE INGREDIENTS, AND METHOD FOR PREPARING SAME
WO 13.01.2022
Int.Class A61K 36/489
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
489Sophora, e.g. necklacepod or mamani
Appl.No PCT/KR2020/010477 Applicant BIOKOS CO., LTD. Inventor KIM, Sung Hyun
The present invention relates to a herbal composition for alleviating or treating atopic dermatitis, and to a method for preparing same, and more specifically, to a herbal composition suitable for use in the alleviation or treatment of atopic dermatitis, which comprises a distillate of a hot-water extract of a mixture comprising 3-5 parts by weight of Sophorae radix, 3-5 parts by weight of Sophorae Flos, 4-6 parts by weight of Scutellariae Radix, 4-6 parts by weight of Angelica dahurica Radix, 3-5 parts by weight of Aloe barbadensis, 3-5 parts by weight of Kalopanax pictus, and 5-7 parts by weight of Forsythiae Fructus, and shows potent anti-inflammatory and antioxidant activities and no toxicity to keratinocytes, and has excellent long-term storage stability, which thus eliminates the need for the use of chemical preservatives and additives that may cause skin irritation. In addition, the present invention relates to a method of preparing the herbal composition.
10.20220008495APPLICATION OF PHLEGMYHEATCLEAR IN PREPARATION OF DRUG FOR TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
US 13.01.2022
Int.Class A61K 36/539
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
539Scutellaria (skullcap)
Appl.No 17160090 Applicant SHANGHAI KAIBAO PHARMACEUTICAL CO., LTD. Inventor Xiaoli Zhang

The invention discloses an application of phlegmyheatclear in preparation of a drug for treatment of acute exacerbation of chronic obstructive pulmonary disease. The present invention studies the effect of phlegmyheatclear on model of rats with acute exacerbation of chronic obstructive pulmonary disease. Results show that high dose, middle dose, or low dose of phlegmyheatclear can, during the acute exacerbation of chronic obstructive pulmonary disease, improve the lung function of the rats and the pathological damage of lung tissues of the rats in different degrees, and it is dose dependent. High dose, middle dose, or low dose of phlegmyheatclear can improve inflammatory reaction in different degrees. For the drug effects, the high dose and the middle dose of phlegmyheatclear are better than the low dose of phlegmyheatclear. Therefore, phlegmyheatclear can be used to prepare a drug for treatment of acute exacerbation of chronic obstructive pulmonary disease.